Skip to main content
Equibles

ONWRY · Onward Medical N.V.

Track ONWRY — free

Use ONWRY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ONWRY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.11 +0.00 (+0.00%) At close · Nov 6
Rebalance outlook locked
Volume · Nov 6 1100 Avg daily vol (3M) 3897

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.11 Open$2.11 Day$2.11–2.11 52W close$2.11–5.60 Avg vol 30d4K Short int2K · 9.0d Short vol100% Last earningsNov 3, 2026 DataApr 2025–Nov 2026

Up next

Next earnings call
Dec 29, 2026 Est · unconfirmed · in 7 wks
Q3 2026 earnings call transcript
call held Nov 3, 2026
Play latest call

Latest documents

2026
Nov 3
Earnings call
Archex systems grew 120% as revenue reached 2.5 million euros

Onward sold or supplied 88 Archex systems via paid evaluation in Q3, up 120% year over year, and reported 2.5 million euros in revenue. The company ended with 73.4 million euros in cash; Empower BP enrollment reached 31 participants.

5 source passages
Welcome to Onward's webcast. So, 88 Archex systems were sold or supplied via paid evaluation in Q3. That's 120% year-over-year growth. Revenue in the third quarter was 2.5 million euros, of which product revenue was 2 million euros. Our current cash balance at the end of the third quarter was 73.4 million euros. We have 31 participants enrolled in the study to date. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-53.2%
Trailing year
Short interest
—
Latest settlement
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 25.6 · fear Equity put/call 0.59
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −27%
below
RSI (14) 35
neutral
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −21%
trailing
6-month return −66%
trailing
YTD return −61%
this year
Relative strength −66%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
▼ -4.9% MoM · 9.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 138%
annualized · 1-yr
Max drawdown −66%
past year
ATR 10.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−27% Bearish
RSI (14)
35 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
▼ -4.9% MoM · 9.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $2 Now $2 · 0% Range high $6
vs 50-day avg -27%

Illustrative technical + ownership context — a signal mix, not investment advice.

At a glance

key data from every section
Short & Settlement
Short Interest Falling
Shares short
2.1K
Days to cover
9.0d
Change
-110 sh
View
Short Volume
Short vol %
100%
As of
Nov 6, 2026
Short Total
View
Fails to Deliver
FTD shares
4.1K
Value
$11.0K
As of
Jul 29, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 28, 2026
Off-exch Lit
View
Earnings & Events
Webcasts
Last webcast
Nov 3, 2026
View

Performance

5D 20D 120D MTD YTD
ONWRY -20.1% -21.0% -66.5% -31.1% -60.8%
SPY -2.7% -5.6% -0.5% -2.7% +7.8%
vs SPY -17.4% -15.4% -66.0% -28.4% -68.6%
Key facts CIK 2059986 CUSIP 68339U102 Visit website Investor relations